News: Novartis to cut thousands of jobs as part of restructuring: Report

Employee Relations

Novartis to cut thousands of jobs as part of restructuring: Report

Swiss drugmaker Novartis will slash thousands of jobs worldwide as it integrates its pharma and oncology operations in a reorganization announced last week.
Novartis to cut thousands of jobs as part of restructuring: Report

Swiss drugmaker Novartis will cut thousands of jobs globally as part of a reorganisation announced last week that would unite its pharma and oncology operations. Swiss newspaper Tages-Anzeiger first reported the plans, citing unnamed sources, according to a report by Reuters. 

More than 100 jobs might be lost at Novartis' Swiss plants in Rotkreuz and Basel, according to the report.

A Novartis representative told Reuters that efficiencies would come through leaner structures, which would "inevitably lead to roles being impacted," but that it was too early to disclose particular numbers.

The Swiss manufacturer, which employs roughly 108,000 people globally, said this week that it was combining its pharmaceuticals and oncology divisions into an innovative medicines (IM) company to streamline its structure and save at least $1 billion by 2024.

The business expects the new structure to be completely operational by the end of 2022, the report added.

Read full story

Topics: Employee Relations, #Layoffs

Did you find this story helpful?

Author

QUICK POLL

What are the top work tech investment focus areas for your company currently?

How are you helping to build the future of work?

READ our latest issue for perspectives on the many facets that form tomorrow's workplace.